Hollenberg S M, Klein L W, Parrillo J E, Scherer M, Burns D, Tamburro P, Oberoi M, Johnson M R, Costanzo M R
Section of Cardiology, Rush-Presbyterian-St Luke's Medical Center, Chicago, Illinois, USA.
Circulation. 2001 Dec 18;104(25):3091-6. doi: 10.1161/hc5001.100796.
Coronary endothelial dysfunction may be an early marker for cardiac allograft vasculopathy (CAV) in orthotopic heart transplant recipients. Using serial studies with intravascular ultrasound and Doppler flow-wire measurements, we have previously demonstrated that annual decrements in coronary endothelial function are associated with progressive intimal thickening. The present study tested whether endothelial dysfunction predicts subsequent clinical events, including cardiac death and CAV development.
Seventy-three patients were studied yearly beginning at transplantation until a prespecified end point was reached. End points were angiographic evidence of CAV (>50% stenosis) or cardiac death (graft failure or sudden death). At each study, coronary endothelial function was measured with intracoronary infusions of adenosine (32-microgram bolus), acetylcholine (54 microgram over 2 minutes), and nitroglycerin (200 microgram) into the left anterior descending coronary artery; intravascular ultrasound images and Doppler velocities were recorded simultaneously. Of the 73 patients studied, 14 reached an end point during the study (6 CAV and 8 deaths, including 4 with known CAV, 1 graft failure, and 3 sudden). On the last study performed, the group with an end point had decreased epicardial (constriction of 11.1+/-2.9% versus dilation of 1.7+/-2.2%, P=0.01) and microvascular (flow increase of 75+/-20% versus 149+/-16%, P=0.03) endothelium-dependent responses to acetylcholine compared with the patients who did not reach an end point. Responses to adenosine and nitroglycerin did not differ significantly.
Endothelial dysfunction, as detected by abnormal responses to acetylcholine, preceded the development of clinical end points. These data implicate endothelial dysfunction in the development of clinically significant vasculopathy and suggest that serial studies of endothelial function have clinical utility.
冠状动脉内皮功能障碍可能是原位心脏移植受者心脏移植血管病变(CAV)的早期标志物。我们之前通过血管内超声和多普勒血流导丝测量的系列研究表明,冠状动脉内皮功能的年度下降与内膜逐渐增厚有关。本研究旨在测试内皮功能障碍是否能预测随后的临床事件,包括心源性死亡和CAV的发生。
对73例患者从移植开始每年进行研究,直至达到预先设定的终点。终点为CAV的血管造影证据(狭窄>50%)或心源性死亡(移植失败或猝死)。在每次研究中,通过向左前降支冠状动脉内注入腺苷(32微克推注)、乙酰胆碱(2分钟内54微克)和硝酸甘油(200微克)来测量冠状动脉内皮功能;同时记录血管内超声图像和多普勒速度。在研究的73例患者中,14例在研究期间达到终点(6例CAV和8例死亡,包括4例已知CAV、1例移植失败和3例猝死)。在最后一次研究时,与未达到终点的患者相比,达到终点的组对乙酰胆碱的外膜(收缩11.1±2.9% vs 扩张1.7±2.2%,P = 0.01)和微血管(血流增加75±20% vs 149±16%,P = 0.03)内皮依赖性反应降低。对腺苷和硝酸甘油的反应无显著差异。
乙酰胆碱反应异常所检测到的内皮功能障碍先于临床终点的出现。这些数据表明内皮功能障碍与具有临床意义的血管病变发展有关,并提示内皮功能的系列研究具有临床应用价值。